Etonogestrel/Estradiol

依托孕烯/雌二醇

Report date: 2022/07/04 19:38:02

Base Information

Drug NameEtonogestrel/Estradiol
Drug Alias Nameetonogestrel + estradiol雌二醇/依托孕烯etonogestrel + 17-beta-estradioletonogestrel + high-dose 17-beta-estradiolEstradiol/Etonogestrel +[9] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsContraceptionDysmenorrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenPolandNetherlands +[14] 
CombinationsYes EstradiolEtonogestrel
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrganon & Co
Active IndicationsN/A
Inactive IndicationsContraceptionDysmenorrhea

Other Information

ATC CodeN/A
Related LinksN/A